Penicillin failure in the treatment of acute and relapsing tonsillopharyngitis is associated with copathogens and alteration of microbial balance: A role for cephalosporins

Clinical Pediatrics

Volumn 46, Issue 4 SUPPL., 2007, Pages

  Brook, Itzhak ^a,b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

lactamase; Bacterial interference; Cephalosporins; Group A streptococcus; Penicillin; Pharyngotonsillitis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFADROXIL; CEFALEXIN; CEFALOTIN; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; ERYTHROMYCIN; LINCOMYCIN; MACROLIDE; PENICILLIN G; PENICILLIN V; PLACEBO; PREBIOTIC AGENT; ANTIINFECTIVE AGENT; PENICILLIN DERIVATIVE;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL GROWTH; BACTERIUM ISOLATE; CHILD; CLINICAL TRIAL; DRUG ACTIVITY; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; HAEMOPHILUS INFLUENZAE; HUMAN; MORAXELLA CATARRHALIS; MOUTH FLORA; OTITIS MEDIA; PHARYNGITIS; PREVOTELLA; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; TONSILLITIS; TREATMENT FAILURE; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION; ANTIBIOSIS; ANTIBIOTIC THERAPY; ARTICLE; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; PHARYNGOTONSILLITIS; RELAPSE; STREPTOCOCCAL PHARYNGITIS;

EID: 34247243225     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922807299466     Document Type: Review

References (48)

1. Kaplan EL, Johnson DR Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A strepharyngo-tonsillitisococci from children with acute pharyngitis. Pediatrics. 2001 ; 108: 1180-1186.
2. Kaplan EL, Gastanaduy AS, Huwe BB The role of the carrier in treatment failures after antibiotic for group A streptococci in upper respiratory tract. J Lab Clin Med. 1981 ; 98: 326-335.
3. Brook I., Hirokawa R. Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci: a prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin Pediatr. 1985 ; 24: 331-336.
4. Brook I. Treatment of patients with acute recurrent tonsillitis due to group A beta-haemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989 ; 24: 227-233.
5. Kaplan EL, Johnson DR Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988 ; 113: 400-403.
6. Holm S., Henning C., Grahn E., Lomberg H., Staley H. Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group. Scand J Infect Dis. 1995 ; 27: 221-228.
7. Holm SE, Roos K., Stromberg A. A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatr Infect Dis J. 1991 ; 10: S68 - S71.
8. Brook I. Role of beta-lactamase - producing bacteria in the persistence of strepharyngo-tonsillitisococcal tonsillar infection. Rev Infect Dis. 1984 ; 6: 601-607.
9. Grahn E., Holm SE Bacterial interference in the throat flora during a strepharyngo-tonsillitisococcal tonsillitis outbreak in an apartment house area. Zbl Bakl Hyg A. 1983 ; 256: 72-79.
10. Lafontaine ER, Wall D., Vanlerberg SL, Donabedian H., Sledjeski DD Moraxella catarrhalis coaggregates with Strepharyngo-tonsillitisococcus pyogenes and modulates interactions of S pyogenes with human epithelial cells. Infect Immun. 2004 ; 72: 6689-6693.
11. Brook I. Beta-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch Otolaryngol. 1984 ; 110: 228-231.
12. Socransky SS, Manganiello SD The oral micro flora of man from birth to senility. J Periodontol. 1971 ; 42: 485-496.
13. Brook I. Emergence and persistence of beta-lactamase - producing bacteria in the oropharynx following penicillin treatment. Arch Otolaryngol Head Neck Surg. 1988 ; 114: 667-670.
14. Brook I., Gober AE Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin Infect Dis. 1996 ; 22: 143-145.
15. Brook I., Gober AE Emergence of beta-lactamase producing aerobic and aerobic bacteria in the oro-pharynx of children following penicillin chemotherapy. Clin Pediatr. 1984 ; 23: 338-341.
16. Brook I. Role of beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A strepharyngo-tonsillitisococci. Pediatr Infect Dis. 1985 ; 4: 491-495.
17. Brook I., Yocum P., Friedman EM Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Ann Otol Rhinol Laryngol. 1981 ; 90: 261-263.
18. Reilly S., Timmis P., Beeden AG, Willis AT Possible role of the anaerobe in tonsillitis. J Clin Pathol. 1981 ; 34: 542-547.
19. Tuner K., Nord CE Beta-lactamase - producing anaerobic bacteria in recurrent tonsillitis. J Antimicrob Chemother. 1982 ; 10 (suppl A): 153-156.
20. Chagollan J., Macias JR, Gil JS Flora indigena de las amigdales. Invest Med Int. 1984 ; 11: 36-39.
21. Kielmovitch IH, Keleti G., Bluestone CD, Wald ER, Gonzales C. Microbiology of obstructive tonsillar hypertrophy and recurrent tonsillitis. Arch Otolaryngol Head Neck Surg. 1989 ; 115: 721-725.
22. Brook I., Yocum P., Foote PA Jr. Changes in the core tonsillar bacteriology of recurrent tonsillitis, 1977-1993. Clin Infect Dis. 1995 ; 21: 171-176.
23. Brook I., Yocum P. Quantitative measurement of beta-lactamase level in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand. 1984 ; 98: 446-460.
24. Brook I. Beta-lactamase-producing bacteria and their role in infection. Rev Med Microbiol. 2005 ; 16: 91-99.
25. Brook I., Gober AE Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A strepharyngo-tonsillitisococcal pharyngotonsillitis. Arch Otolaryngol Head Neck Surg. 1995 ; 121: 1405-1409.
26. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005 ; 133: 139-146.
27. Brook I., Gober AE Bacterial interference by aerobic and anaerobic bacteria in children with recurrent group A beta-hemolytic strepharyngo- tonsillitisococcal tonsillitis. Arch Otolaryngol Head Neck Surg. 1999 ; 125: 552-554.
28. Roos K., Grahn E., Holm SE, Johansson H., Lind L. Interfering alpha-strepharyngo-tonsillitisococci as a protection against recurrent strepharyngo-tonsillitisococcal tonsillitis in children. Int J Pediatr Otol. 1993 ; 25: 141-148.
29. Roos K., Holm SE, Grahn E., Lind L. Alpha-strepharyngo-tonsillitisococci as supplementary treatment of recurrent strepharyngo-tonsillitisococcal tonsillitis: a randomized placebo-controlled study. Scand J Infect Dis. 1993 ; 25: 31-35.
30. Roos K., Holm SE, Grahn-Hakansson E., Lagergren L. Recolonization with selected alpha-strepharyngo-tonsillitisococci for prophylaxis of recurrent strepharyngo-tonsillitisococcal pharyngotonsillitis - a randomized placebo-controlled multicentre study. Scand J Infect Dis. 1996 ; 28: 459-462.
31. Falck G., Grahn-Håkansson E., Holm SE, Roos K., Lagergren L. Tolerance and efficacy of interfering alpha-strepharyngo-tonsillitisococci in recurrence of strepharyngo-tonsillitisococcal pharyngotonsillitis: a placebo-controlled study. Acta Otolaryngol (Stockh). 1999 ; 119: 944-948.
32. Brook I., Gober AE Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxicillin-clavulanate. J Med Microbiol. 2005 ; 54: 553-556.
33. Brook I., Gillmore JD Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic strepharyngo-tonsillitisococci. Antimicrob Agents Chemother. 1993 ; 37: 1452-1455.
34. Brook I. The role of anaerobic bacteria in tonsillitis. Int J Pediatr Otorhinolaryngol. 2005 ; 69: 9-19.
35. Brook I., Gillmore JD Enhancement of growth of group A beta-hemolytic strepharyngo-tonsillitisococci in mixed infections with aerobic and anaerobic bacteria. Clin Microbiol Infect. 1996 ; 1: 179-182.
36. Brook I., Gober AE Increased recovery of Moraxella catarrhalis and Haemophillus influenzae in association with group A beta-hemolytic strepharyngo-tonsillitisococci in healthy children and those with pharyngo-tonsillitis. J Med Microb. 2006 ; 55: 989-992.
37. Casey JR, Pichichero ME Meta-analysis of cephalosporins versus penicillin for treatment of group A strepharyngo-tonsillitisococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004 ; 38: 1526-1534.
38. Pichichero ME Cephalosporins are superior to penicillin for treatment of strepharyngo-tonsillitisococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993 ; 12: 268-274.
39. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH Practice guidelines for the diagnosis and management of group A strepharyngo- tonsillitisococcal pharyngitis. Clin Infect Dis. 2002 ; 35: 113-125.
40. Casey JR, Pichichero ME Meta-analysis of short course antibiotic treatment for group a strepharyngo-tonsillitisococcal tonsillopharyngitis. Pediatr Infect Dis J. 2005 ; 24: 909-917.
41. Brook I., Foote PA Efficacy of penicillin versus cefdinir in eradication of group A strepharyngo-tonsillitisococciand tonsillar flora. Antimicrob Agents Chemother. 2005 ; 49: 4787-4788.
42. Smith TD, Huskins WC, Kim KS, Kaplan EL Efficacy of beta-lactamase- resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. J Pediatr. 1987 ; 1 10: 777-782.
43. Rathore MH, Jenkins SG Group A beta-hemolytic strepharyngo- tonsillitisococcus: issue of resistance. Pediatr Infect Dis J. 1993 ; 12: 354-355.
44. Richter SS, Heilmann KP, Beekmann SE, et al. Macrolide-resistant Strepharyngo-tonsillitisococcus pyogenes in the United States, 2002-2003. Clin Infect Dis. 2005 ; 41: 599-608.
45. Martin JM, Green M., Barbadora KA, Wald ER Erythromycin-resistant group A strepharyngo-tonsillitisococci in schoolchildren in Pittsburgh. N Engl J Med. 2002 ; 346: 1200-1206.
46. Tanz R., Shulman T., Sroka A., Marubio S., Brook I., Yogev R. Lack of Influence of beta-lactamase-production flora on recovery of group A strepharyngo-tonsillitisococci after treatment of acute pharyngitis. J Pediatr. 1990 ; 117: 859-863.
47. Brook I., Gober AE Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J Antimicrob Chemother. 1998 ; 41: 489-492.
48. Tanz RR, Shulman ST Strepharyngo-tonsillitisococcal pharyngitis: the carrier state, definition, and management. Pediatr Ann. 1998 ; 27: 281-285.